(Q40762003)

23 September 2017

0 references

Can novel therapeutics halt the amyloid cascade? (English)

1 reference

23 September 2017

3

Philip Scheltens

1 reference

23 September 2017

Niels D Prins

1

1 reference

23 September 2017

Pieter Jelle Visser

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

9 April 2010

1 reference

Alzheimers Research & Therapy

23 September 2017

1 reference

23 September 2017

2

1 reference

23 September 2017

2

1 reference

23 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1186/alzrt28

23 September 2017

0 references

cites work

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

The amyloid hypothesis for Alzheimer's disease: a critical reappraisal

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Alzheimer disease: mechanistic understanding predicts novel therapies

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Treatment of Alzheimer's disease: current status and new perspectives.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

The effect of APOE genotype on clinical phenotype in Alzheimer disease

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876783

2 December 2018

Identifiers

DOI

10.1186/ALZRT28

1 reference

Dimensions Publication ID

23 September 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/alzrt28

1 reference

23 September 2017

PubMed publication ID

20388189

1 reference